KAIST & CMU unveils Amuse, a songwriting AI-collaborator to help create music
Peer-Reviewed Publication
Updates every hour. Last Updated: 1-Nov-2025 15:11 ET (1-Nov-2025 19:11 GMT/UTC)
A research team from the Max Planck Institute for Chemistry in Mainz and Heidelberg University has, for the first time, used the German environmental satellite EnMAP (Environmental Mapping and Analysis Program) to simultaneously detect the two key air pollutants carbon dioxide (CO₂) and nitrogen dioxide (NO₂) in emission plumes from power plants – with an unprecedented spatial resolution of just 30 meters. The newly developed method allows for tracking of industrial emissions from space with great precision and enables atmospheric processes to be analyzed in detail. The results were published in the journal Environmental Research Letters.
A research team led by POSTECH Professor Hyung Joo Lee found that NO2 exposure levels were consistently higher in areas with higher socioeconomic status—an outcome shaped by South Korea’s distinctive history of rapid economic development and urban planning.
- Over 30% faster than all previously known substances
- Development patent pending
- Completely new class of substances discovered
Solid-state batteries are considered a key technology for the future: they can store more energy and do not rely on flammable materials like current lithium-ion batteries. Researchers at TUM and TUMint.Energy Research have now taken a significant step towards improving solid-state batteries. They developed a new material made of lithium, antimony and scandium that conducts lithium ions more than 30% faster than any previously known material.
A research team led by Dr. Bon-Cheol Ku and Dr. Seo Gyun Kim of the Carbon Composite Materials Research Center at the Korea Institute of Science and Technology (KIST) and Professor Yuanzhe Piao of Seoul National University (SNU) has developed a high-performance supercapacitor that is expected to become the next generation of energy storage devices.
Researchers from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) and local biotechnology company Intra-ImmuSG have announced promising outcomes from a Phase II clinical trial of a novel cancer immunotherapy, PRL3-zumab. Published in Cell Reports Medicine, the study shows PRL3-zumab safely slows disease progression in patients with advanced solid cancers unresponsive to existing treatments.